Gyros Announces Changes to its Management Team

Gyros AB has announced the appointment of Dr. Jon-Sverre Schanche as Chief Technology Officer and Vice President Technical Affairs.

Dr. Schanche’s appointment comes as Nils Kristensen, COO and VP Technical Operations, and Stephan Hoffmann, VP Business Development, leave the company.

Dr. Schanche has almost thirty years of industrial R&D and management experience. In his new role he will hold responsibility for business and product development as well as production and manufacturing.

Most recently, Dr. Schanche was Vice President R&D at DAKO Denmark A/S where he established a system development organization for in vitro diagnostic products.

Before this, he held executive roles within the drug discovery and biotechnology supply industry, including Vice President of R&D in Personal Chemistry AB and Biotage AB and several senior management positions in Amersham Pharmacia Biotech (now GE Healthcare), including General Manager for the Norwegian R&D site.

Erik Walldén, CEO at Gyros, commented, “We are extremely pleased to make this appointment. Dr. Schanche brings a wealth of experience that will further enhance Gyros’ ability to develop its nanoscale immunoassay platform for time-critical workflows in the biopharmaceutical industry”.